KKR invests $475m in Alexandria Real Estate Equities’ Campus Point

Alexandria Real Estate Equities announced a $475 million investment in its San Diego Campus Point by KKR, which will hold a 49% stake. The joint venture is expected to provide distributions of at least 5.5% annually to KKR. Alexandria has faced financial challenges since 2021 and has been selling assets to maintain liquidity.

KKR & Co. (KKR) acquired a 49% stake in Alexandria Real Estate Equities' (ARE) Campus Point, a 2M sq. ft. life science Megacampus in San Diego, for $475M. The deal includes tenants like Novartis (NVS).

KKR invested $475m for a 49% stake in a San Diego life science campus owned by Alexandria Real Estate Equities, forming a partnership. The deal gives KKR indirect 28.5% ownership. Both firms aim to drive long-term value and development.

KKR invested $475 million in Alexandria Real Estate Equities' (ARE) Campus Point life science campus in San Diego, acquiring a 49% equity interest. ARE retains control and will use the capital for development and leasing. Campus Point is 98% leased to major tenants like Novartis and Bristol Myers Squibb, offering long-term income.

KKR (NYSE:KKR) invested $475M in Alexandria Real Estate Equities' (NYSE:ARE) San Diego life science campus, acquiring a 49% stake. The deal provides capital for development and leasing. Campus Point, with tenants like Novartis and Bristol Myers Squibb, has 98% of rental revenue under long-term leases. Alexandria retains control of operations.

KKR acquired the Campus Point Megacampus in San Diego for $475 million. Tenants include Eli Lilly, Novartis, and Bristol Myers Squibb. Alexandria Real Estate Equities, the seller, will use proceeds to optimize capital structure and support future investments. KKR and Alexandria are publicly traded (KKR, ARE).